Description
Tesamorelin is studied in experimental models examining its interaction with GHRH receptors (GHRH-R) and associated downstream signaling pathways. Research interest includes analysis of receptor-binding dynamics, signal transduction behavior, and activation of pathways such as cAMP-mediated signaling in controlled in vitro and preclinical models. Investigations may also explore peptide stability, structural modifications, and their influence on signaling duration and receptor engagement. Common laboratory applications include receptor kinetics studies, pathway mapping, and mechanistic evaluation of peptide-mediated endocrine signaling responses.
Overview
Tesamorelin is a synthetic peptide analog of growth hormone–releasing hormone (GHRH), consisting of a modified amino acid sequence designed for stability in controlled research environments. This compound is commonly utilized in laboratory settings focused on hypothalamic–pituitary signaling and peptide-receptor interaction studies. This material is provided strictly for analytical and investigational use in controlled research environments. It is not intended for human or veterinary use. Product descriptions are presented for educational and catalog reference purposes only.
Chemical Makeup
Amino Acid Sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg
Molecular Formula: C221H366N72O67S
Molecular Weight: 5135.90 g/mol
CAS Number: 218949-48-5
Reviews
There are no reviews yet.